Safety of the concomitant use of caspofungin and cyclosporin A in patients with invasive fungal infections
César Sanz-Rodrı́guez(Merck Biopharma Co., Ltd. (Japan)), C Solano(Hospital Clínico Universitario de Valencia), P. Morales(Hospital Universitari i Politècnic La Fe), M.L. Martino(Hospital Universitario Virgen del Rocío), Pedro García-Sánchez(Hospital Clínico San Carlos), M Rovira(Hospital Clínic de Barcelona), M. Jurado(Hospital Universitario Virgen de las Nieves), R. Arranz(Hospital Universitario de La Princesa), Monica López‐Duarte(Marqués de Valdecilla University Hospital)
Cited by 85
Related Papers
Vorinostat in solid and hematologic malignancies
|Journal of Hematology & Oncology|2009|204
Chronic depolarization prevents programmed death of sympathetic neurons in vitro but does not support growth: requirement for Ca2+ influx but not Trk activation
|Journal of Neuroscience|1995|170
Primary hepatic lymphoma
|Cancer|2001|157
Empiric broad-spectrum antibiotic therapy of nosocomial pneumonia in the intensive care unit: a prospective observational study
|Critical Care|2006|128
Evaluation of the Long-Term Tolerability and Clinical Benefit of Vorinostat in Patients With Advanced Cutaneous T-Cell Lymphoma
|Clinical Lymphoma & Myeloma|2009|97